home / stock / srzn / srzn news


SRZN News and Press, Surrozen Inc. From 08/06/25

Stock Information

Company Name: Surrozen Inc.
Stock Symbol: SRZN
Market: NASDAQ
Website: surrozen.com

Menu

SRZN SRZN Quote SRZN Short SRZN News SRZN Articles SRZN Message Board
Get SRZN Alerts

News, Short Squeeze, Breakout and More Instantly...

SRZN - Surrozen to Present at Upcoming Healthcare Investor Conference

SOUTH SAN FRANCISCO, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate the Wnt pathway for tissue repair and regeneration, with a...

SRZN - How the (SRZN) price action is used to our Advantage

2025-06-18 18:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

SRZN - (SRZN) Technical Pivots with Risk Controls

2025-05-26 21:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

SRZN - Surrozen files $150M mixed securities shelf

2025-05-20 16:39:18 ET More on Surrozen Seeking Alpha’s Quant Rating on Surrozen Historical earnings data for Surrozen Financial information for Surrozen Read the full article on Seeking Alpha For further details see: Surrozen files $150M m...

SRZN - Surrozen Granted Patent from U.S. Patent and Trademark Office Directed to Antibody-Based Molecules Targeting Key Receptors in the Wnt Pathway

Newly granted patent is part of the expanding intellectual property portfolio directed to: -generating novel and selective Wnt surrogate molecules with potentially broad therapeutic utility and -incorporating novel discoveries related to requirements for efficient and selective Wn...

SRZN - Surrozen GAAP EPS of -$7.43 misses by $5.65, revenue of $0.98M

2025-05-09 16:38:24 ET More on Surrozen Seeking Alpha’s Quant Rating on Surrozen Historical earnings data for Surrozen Financial information for Surrozen Read the full article on Seeking Alpha For further details see: Surrozen GAAP EPS of -...

SRZN - Surrozen Reports First Quarter 2025 Financial Results and Provides Business Update

SOUTH SAN FRANCISCO, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate the Wnt pathway for tissue repair and regeneration, with a focu...

SRZN - Surrozen files to sell 5.21M shares of common stock for holders

2025-04-23 16:37:22 ET More on Surrozen Seeking Alpha’s Quant Rating on Surrozen Financial information for Surrozen Read the full article on Seeking Alpha For further details see: Surrozen files to sell 5.21M shares of common stock for holders

SRZN - When (SRZN) Moves Investors should Listen

2025-04-04 10:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

SRZN - Surrozen Provides Fourth Quarter and Full Year 2024 Financial Results and Business Updates

SOUTH SAN FRANCISCO, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a company pioneering targeted therapeutics that selectively activate the Wnt pathway for tissue repair and regeneration, with a focus on sev...

Previous 10 Next 10